Efficacy and Safety of Retatrutide, a Novel GLP-1, GIP, and Glucagon Receptor Agonist for Obesity Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Proceedings (Baylor University
For endometriosis, a condition frequently treated with progestins, this discovery opens a new theoretical possibility: GLP-1 medications might someday enhance response to hormonal therapy
This peptide therapy stands out for its unique properties and does not increase cortisol, prolactin, or hunger, making it a safe option for those seeking various health benefits
While IVIG is FDA-approved for several neurological conditions (such as chronic inflammatory demyelinating polyneuropathy), its use for SFN is often considered off-label
It is widely accepted that GPX4 plays an inhibitory role in ferroptosis